These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 9657124)
41. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871 [TBL] [Abstract][Full Text] [Related]
42. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367 [TBL] [Abstract][Full Text] [Related]
43. The CT evaluation of transcatheter arterial chemo-embolization, using iodized oil for hepatocellular carcinoma. Isaza MO; Kuroda C; Marukawa T; Tokunaga K; Hosoki T; Masuike M; Monden M; Sakurai M; Kozuka T Med J Osaka Univ; 1990 Mar; 39(1-4):23-32. PubMed ID: 1369648 [No Abstract] [Full Text] [Related]
44. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases]. Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429 [No Abstract] [Full Text] [Related]
45. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218 [TBL] [Abstract][Full Text] [Related]
46. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395 [TBL] [Abstract][Full Text] [Related]
47. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Rand T; Loewe C; Schoder M; Schmook MT; Peck-Radosavljevic M; Kettenbach J; Wolf F; Schneider B; Lammer J Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943 [TBL] [Abstract][Full Text] [Related]
48. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation]. Zhou DW; Zhang ZJ; Sun W Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):786-8. PubMed ID: 15949389 [No Abstract] [Full Text] [Related]
51. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668 [TBL] [Abstract][Full Text] [Related]
52. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585 [TBL] [Abstract][Full Text] [Related]
53. Treatment of unresectable hepatocellular carcinoma. Stuart K N Engl J Med; 1995 Sep; 333(13):877; author reply 878. PubMed ID: 7651488 [No Abstract] [Full Text] [Related]
54. Chemoembolization and bland embolization: a critical appraisal. Befeler AS Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274 [TBL] [Abstract][Full Text] [Related]
55. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Dharancy S; Boitard J; Decaens T; Sergent G; Boleslawski E; Duvoux C; Vanlemmens C; Meyer C; Gugenheim J; Durand F; Boillot O; Declerck N; Louvet A; Canva V; Romano O; Ernst O; Mathurin P; Pruvot FR Liver Transpl; 2007 May; 13(5):665-71. PubMed ID: 17427172 [TBL] [Abstract][Full Text] [Related]
56. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690 [TBL] [Abstract][Full Text] [Related]
57. Chemoembolization for small hepatocellular carcinoma. Nakamura H; Oi H Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():144-7. PubMed ID: 9210897 [No Abstract] [Full Text] [Related]
58. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Spreafico C; Marchianò A; Regalia E; Frigerio LF; Garbagnati F; Andreola S; Milella M; Lanocita R; Mazzaferro V Radiology; 1994 Sep; 192(3):687-90. PubMed ID: 8058934 [TBL] [Abstract][Full Text] [Related]
59. Treatment of hepatoma by liver transplantation. Schwartz ME; Sheiner P; Mor E; Sung M; Miller CM Transplant Sci; 1994 Sep; 4(1):1-3; discussion 3-4. PubMed ID: 7804688 [No Abstract] [Full Text] [Related]
60. Temporary occlusion of two hepatic veins for chemoembolization of hepatocellular carcinoma with arteriohepatic vein shunts. Murata S; Tajima H; Abe Y; Fukunaga T; Nakazawa K; Mohamad RA; Kumazaki T AJR Am J Roentgenol; 2005 Feb; 184(2):415-7. PubMed ID: 15671355 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]